WEDELL-WEDELLSBORG JOHAN sold 7.5% of their position (49.36K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.34M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/29/2019ACC: 0001104659-19-047982
Director10% Owner
Since Sep 2018
-49.36K
Net shares
Net seller
$1.34M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
49.36K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−19.80K
Price / share
$27.18
Trade value
$538.30K
% of position
3.0%
8/27/2019
654.16K→634.35K
Common Stock
Indirect
Shares
−29.55K
Price / share
$27.02
Trade value
$798.50K
% of position
4.7%
8/28/2019
634.35K→604.80K
Total
Net shares
−49.36K
Net value
-$1.34M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/27/2019 | S · Sale | −19.80K | $27.18 | $538.30K | 3.0% | 654.16K | 634.35K |
| Common Stock Indirect | 8/28/2019 | S · Sale | −29.55K | $27.02 | $798.50K | 4.7% | 634.35K | 604.80K |
| Total | −49.36K | -$1.34M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned5.01M
Total
5.01M indirect5.01M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5.01M | Indirect |
| Total | 5.01M | 5.01M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported